Goldilocks and the Three Trials: Clinical Trials Targeting the αvβ6 Integrin in Idiopathic Pulmonary Fibrosis

Am J Respir Crit Care Med. 2022 Nov 1;206(9):1062-1063. doi: 10.1164/rccm.202208-1579ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antigens, Neoplasm / therapeutic use
  • Humans
  • Idiopathic Pulmonary Fibrosis* / drug therapy
  • Integrin beta Chains
  • Integrins / therapeutic use

Substances

  • integrin beta6
  • Antibodies, Monoclonal
  • Integrins
  • Integrin beta Chains
  • Antigens, Neoplasm